# The Benefit of Add On DLBS1033 for Ischemic Stroke Patient

> **NCT04425590** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Duta Wacana Christian University** · enrollment: 180 (estimated)

## Conditions studied

- Ischemic Stroke

## Interventions

- **DRUG:** DLBS1033
- **DRUG:** Aspirin
- **DRUG:** Statin
- **DRUG:** Vit B12

## Key facts

- **NCT ID:** NCT04425590
- **Lead sponsor:** Duta Wacana Christian University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-04-01
- **Primary completion:** 2020-08
- **Final completion:** 2020-08
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2020-06-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04425590

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04425590, "The Benefit of Add On DLBS1033 for Ischemic Stroke Patient". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04425590. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*